Holen Sie sich die Stockscreener-App
39.13
2.38%
0.91
Handel nachbörslich:
39.14
0.010
+0.03%
Schlusskurs vom Vortag:
$38.22
Offen:
$38.75
24-Stunden-Volumen:
3.49M
Relative Volume:
0.70
Marktkapitalisierung:
$79.79B
Einnahmen:
$40.95B
Nettoeinkommen (Verlust:
$5.16B
KGV:
18.03
EPS:
2.1708
Netto-Cashflow:
$6.10B
1W Leistung:
+6.48%
1M Leistung:
+2.22%
6M Leistung:
+7.06%
1J Leistung:
-4.98%
1-Tages-Spanne:
$38.62
$39.33
1-Wochen-Bereich:
$37.07
$39.33
52-Wochen-Spanne:
$31.71
$44.67
Gsk Plc Adr Stock (GSK) Company Profile
Vergleichen Sie GSK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GSK
Gsk Plc Adr
|
39.13 | 77.06B | 40.95B | 5.16B | 6.10B | 2.1708 |
|
LLY
Lilly Eli Co
|
660.49 | 573.22B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
174.42 | 416.11B | 90.62B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
201.47 | 350.91B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
121.20 | 230.97B | 53.40B | 13.68B | 16.81B | 6.9231 |
|
MRK
Merck Co Inc
|
82.71 | 200.57B | 63.43B | 16.42B | 14.72B | 6.49 |
Gsk Plc Adr Stock (GSK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Herabstufung | Berenberg | Buy → Hold |
| 2025-04-15 | Eingeleitet | Exane BNP Paribas | Neutral |
| 2025-02-12 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-11-15 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-11-12 | Herabstufung | Jefferies | Buy → Hold |
| 2024-10-31 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-07-08 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-30 | Eingeleitet | Goldman | Neutral |
| 2024-03-04 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-02-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-01-23 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-01-16 | Fortgesetzt | UBS | Buy |
| 2024-01-03 | Hochstufung | Jefferies | Hold → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Reduce |
| 2023-03-17 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2023-02-27 | Fortgesetzt | Goldman | Buy |
| 2023-01-03 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-12-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-11-11 | Herabstufung | UBS | Neutral → Sell |
| 2022-09-15 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2022-09-08 | Herabstufung | Jefferies | Buy → Hold |
| 2022-08-05 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-21 | Fortgesetzt | Citigroup | Neutral |
| 2022-02-11 | Herabstufung | DZ Bank | Buy → Hold |
| 2021-11-05 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-06-24 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2021-03-23 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-02-04 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2021-01-20 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2021-01-15 | Eingeleitet | Deutsche Bank | Hold |
| 2020-11-02 | Hochstufung | Liberum | Hold → Buy |
| 2020-09-29 | Eingeleitet | Berenberg | Buy |
| 2020-02-12 | Herabstufung | Shore Capital | Hold → Sell |
| 2020-01-16 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-12-02 | Eingeleitet | SVB Leerink | Outperform |
| 2019-11-21 | Hochstufung | UBS | Neutral → Buy |
| 2019-10-11 | Hochstufung | Cantor Fitzgerald | Hold → Buy |
| 2019-09-03 | Fortgesetzt | Citigroup | Neutral |
| 2019-09-03 | Hochstufung | Societe Generale | Sell → Buy |
| 2019-08-13 | Fortgesetzt | JP Morgan | Neutral |
| 2019-06-17 | Fortgesetzt | Morgan Stanley | Underweight |
| 2019-03-08 | Herabstufung | Shore Capital | Buy → Hold |
| 2019-02-22 | Herabstufung | UBS | Buy → Neutral |
| 2019-01-14 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2018-12-11 | Fortgesetzt | Jefferies | Buy |
| 2018-10-09 | Eingeleitet | Guggenheim | Neutral |
| 2018-08-30 | Herabstufung | Liberum | Buy → Hold |
| 2018-04-04 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2018-03-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2018-02-09 | Hochstufung | Kepler | Reduce → Hold |
Alle ansehen
Gsk Plc Adr Aktie (GSK) Neueste Nachrichten
Global Cancer Vaccines Market to Surpass USD 15.00 Billion by 2032, Unlocking Over USD 10 Billion in New Growth Opportunities | MarketsandMarkets™. - GlobeNewswire Inc.
The Best Healthcare Stocks to Buy - Morningstar
What’s Next for Pharma Stocks After Trump’s Drug Price Ultimatum? - Morningstar
Company News for Jul 31, 2025 - The Globe and Mail
GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise - TradingView
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
GSK Plc ADR (GSK) Stock: A Year of Stock Market Dynamics - investchronicle.com
Fifth Third Bancorp Inc. (FITB) Price Performance Over the Years: A Comparative Study - investchronicle.com
Navigating YMM Stock: Full Truck Alliance Co Ltd ADR Journey - investchronicle.com
GDS Holdings Limited ADR (GDS) Stock: Navigating a Year of Volatility - investchronicle.com
The Future of Microvast Holdings Inc: Analyzing MVST - investchronicle.com
SES AI Corporation (SES) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
SKYQ’s Stock Woes: Down -53.24% in 6 Months, Down -53.24% in Just 5 Days - investchronicle.com
Antero Resources Corp (AR) Stock: A Year of Declines and Increases - investchronicle.com
The Psychology of HUYA Inc ADR Inc. (HUYA) Price Performance: Understanding Market Sentiment - investchronicle.com
American Resources Corporation: Analyzing AREC Stock Trends - investchronicle.com
MSP Recovery Inc (MSPR) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Coty Inc (COTY) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Behind Palladyne AI Corp’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com
NVO’s 2025 Market Dance: Down -51.70% – Time to Invest? - investchronicle.com
Celularity Inc (CELU) Stock: A Year of Market Fluctuations - investchronicle.com
Bilibili Inc ADR (BILI) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Captivision Inc Inc. (CAPT) Price Performance: The Role of Supply and Demand - investchronicle.com
Charting the Course: Castellum Inc’s CTM Stock Prospects - investchronicle.com
MBIO Stock: Exploring Mustang Bio Inc’s Growth - investchronicle.com
IBG’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
IBIO’s Market Whiplash: -61.36% YTD Decline, -20.36% Plunge in 30 Days - investchronicle.com
LQR House Inc (YHC) Stock: A Year of Stock Market Dynamics - investchronicle.com
INKT’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Crossmark Global Holdings Inc. Reduces Stock Holdings in ARM Holdings PLC Sponsored ADR (NASDAQ:ARM) - Defense World
FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults - The Globe and Mail
FDA Accepts GSK Filing For Expanded Use Of RSV Shot In Younger Adults - Barchart.com
Argentina Lithium & Energy (CVE:LIT) Shares Down 12.5% – What’s Next? - Defense World
Brown Advisory Inc. Increases Holdings in Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ:BSCQ) - Defense World
Callan Capital LLC Raises Stock Holdings in Alphabet Inc. (NASDAQ:GOOGL) - Defense World
Brown Advisory Inc. Boosts Position in Schwab US Large-Cap ETF (NYSEARCA:SCHX) - Defense World
KBR, Inc. (NYSE:KBR) Holdings Trimmed by M&T Bank Corp - Defense World
Invesco RAFI Developed Markets ex-U.S. ETF (NYSEARCA:PXF) Position Increased by Bank of New York Mellon Corp - Defense World
Verisk Analytics, Inc. (NASDAQ:VRSK) Shares Sold by Stratos Wealth Partners LTD. - Defense World
Post Resch Tallon Group Inc. Has $818,000 Stock Position in NVIDIA Corporation (NASDAQ:NVDA) - Defense World
Alphabet Inc. (NASDAQ:GOOGL) Shares Purchased by Interchange Capital Partners LLC - Defense World
Crossmark Global Holdings Inc. Purchases New Stake in Cushman & Wakefield PLC (NYSE:CWK) - Defense World
4,270 Shares in iShares California Muni Bond ETF (NYSEARCA:CMF) Bought by Crossmark Global Holdings Inc. - Defense World
Wall Street Zen Upgrades LCI Industries (NYSE:LCII) to Buy - Defense World
Citigroup Forecasts Strong Price Appreciation for Establishment Labs (NASDAQ:ESTA) Stock - Defense World
Is Your Investment Portfolio Ready for a US-EU Trade Deal? - Morningstar
Amalgamated Bank Sells 311 Shares of Benchmark Electronics, Inc. (NYSE:BHE) - Defense World
Amalgamated Bank Has $429,000 Stock Position in NetScout Systems, Inc. (NASDAQ:NTCT) - Defense World
Amalgamated Bank Trims Stock Position in National Bank Holdings Corporation (NYSE:NBHC) - Defense World
The 10 Best Companies to Invest in Now - Morningstar
GENFIT (NASDAQ:GNFT) Shares Up 0.7% – Time to Buy? - Defense World
Finanzdaten der Gsk Plc Adr-Aktie (GSK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):